AbbVie Inc. / Pharmacyclics Inc.

North Chicago, Illinois-based biopharmaceutical company AbbVie Inc. said March 4 it will buy Sunnyvale, California-based Pharmacyclics, which specializes in cancer treatment, for $21 billion.